ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY Trademark
Trademark Overview
On Monday, March 2, 2026, a trademark application was filed for ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY trademark a serial number of 99677818. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 2, 2026. This trademark is owned by Seqirus Inc.. The ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information
Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development
General Information
| Serial Number | 99677818 |
| Word Mark | ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY |
| Filing Date | Monday, March 2, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Monday, March 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | The color(s) red, purple, and gray is/are claimed as a feature of the mark. |
| Goods and Services | Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information |
| NOT AVAILABLE | "STUDY CELL-BASED ADJUVANT TECHNOLOGY" |
| Description of Mark | The mark consists of the wording "ALLYNZA STUDY" above the wording "CELL-BASED ADJUVANT TECHNOLOGY". To the left of the wording "ALLYNZA STUDY" is a design of a circle with an arrow-like shape through the circle. The tip of the arrow is a design of a rocket ship. The wording "ALLYNZA STUDY" is in the color purple. The rest of the wording in the mark is in the color gray. The circle element of the design is in the colors red and gray, and the arrow-like element of the design is red and purple with the rocket ship element being in the color purple. |
| Goods and Services | Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 2, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 2, 2026 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Seqirus Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Holly Springs, NC 27540
US |
Trademark Events
| Event Date | Event Description |
| Monday, March 2, 2026 | NEW APPLICATION ENTERED |
| Monday, March 2, 2026 | APPLICATION FILING RECEIPT MAILED |
